Compounds > topotecan
Page last updated: 2024-08-24

topotecan and pheophorbide a

topotecan has been researched along with pheophorbide a in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beijnen, JH; Buitelaar, M; Elferink, RP; Jonker, JW; Kuipers, F; Plosch, T; Rosing, H; Scheffer, GL; Scheper, RJ; Schinkel, AH; Van Der Valk, MA; Wagenaar, E1
Bates, SE; Blayney, M; Mistry, P; Morisaki, K; Polgar, O; Robey, RW; Steadman, K1
Gupta, A; Mao, Q; Unadkat, JD1
Ambudkar, SV; Baer, MR; Bhullar, J; Cai, L; Chen, ZS; Fang, HB; Natarajan, K; Sen, R; Shukla, S1

Other Studies

4 other study(ies) available for topotecan and pheophorbide a

ArticleYear
The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, Nov-26, Volume: 99, Issue:24

    Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bone Marrow Transplantation; Cell Line; Chlorophyll; Chromatography, High Pressure Liquid; Dermatitis, Phototoxic; Diet; Drug Resistance; Female; Fetus; Fibroblasts; Genetic Predisposition to Disease; Medicago sativa; Mice; Mice, Inbred Strains; Mice, Knockout; Molecular Structure; Neoplasm Proteins; Photosensitizing Agents; Porphyria, Hepatoerythropoietic; Porphyrins; Pregnancy; Protoporphyrins; Radiation Chimera; Topotecan

2002
Pheophorbide a is a specific probe for ABCG2 function and inhibition.
    Cancer research, 2004, Feb-15, Volume: 64, Issue:4

    Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Camptothecin; Chlorophyll; Drug Resistance, Neoplasm; Humans; Irinotecan; Neoplasm Proteins; Quinolines; Staurosporine; Topotecan

2004
Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP).
    Journal of pharmaceutical sciences, 2007, Volume: 96, Issue:12

    Topics: Antifungal Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line; Cell Survival; Chlorophyll; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Flow Cytometry; Fluconazole; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Itraconazole; Ketoconazole; Neoplasm Proteins; Pyrimidines; Topotecan; Transfection; Triazoles; Voriconazole

2007
The novel BCR-ABL and FLT3 inhibitor ponatinib is a potent inhibitor of the MDR-associated ATP-binding cassette transporter ABCG2.
    Molecular cancer therapeutics, 2012, Volume: 11, Issue:9

    Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carbocyanines; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Chlorophyll; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; fms-Like Tyrosine Kinase 3; Fusion Proteins, bcr-abl; Humans; Imidazoles; Inhibitory Concentration 50; Mitoxantrone; Neoplasm Proteins; Protein Binding; Pyridazines; Rhodamine 123; Topotecan

2012